At the periphery of the human placenta, trophoblast attaches to the uterine wall. T h e tissue interface contains many anchoring sites, with cytotrophoblast columns that form bridges between the overlying extraembryonic (villous) mesenchyme and the maternal decidual stroma beneath. From the periphery of these columns, large numbers of trophoblast cells detach, migrate through the decidua and eventually colonize and transform maternal arteries. In this way the placenta increases and gives priority to the maternal blood supply to the conceptus. We have shown that when early villous tissue is explanted on a collagen gel in serum-free medium, anchoring-site morphogenesis occurs. Thus, in the presence of placental mesenchyme but in the absence of maternal cells, contact with a permissive extracellular matrix (ECM) is necessary and sufficient for cytotrophoblast column development. Proliferation of trophoblast occurs, followed by differentiation into a columnar cell phenotype in which cells remain attached to one another and to the ECM. At this stage, interaction between fibronectin and integrin a5/3l at the cell surface stabilizes the column and the cells remain as a contiguous multilayered sheet. However, the addition of serum-free conditioned medium from first-trimester placental fibroblasts stimulates cytotrophoblast to detach from the distal column and migrate in streams across the ECM. The removal of insulin-like growth factor I (IGF-I) from the fibroblast medium decreases streaming activity, whereas the addition of exogenous IGF-I (10 ng/ml) to serum-free medium produces a streaming phenotype. In contrast, transforming growth factor /31 (1 0 ng/ml) maintains the cells in a tight sheet. These results suggest the possibility of a paracrine interaction between villous mesenchyme and cytotrophoblast in anchoring sites to stimulate the infiltration of the maternal ECM by trophoblast. Such a mechanism would be self-
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limiting because the signal diminishes with distance from the placenta.
Developmental origins of migratory trophoblast
At the periphery of the placenta, chorionic villi make contact with maternal decidua to create cytotrophoblast columns that form a bridge between the extra-embryonic mesenchyme of the placenta and the maternal decidual stroma [1, 2] .
These cell columns have two functions : they anchor the placenta to maternal tissue and in addition they act as feeder sites for a large population of interstitially migrating cytotrophoblast that breaks away, eventually colonizing and transforming maternal arteries in the placental bed [3, 4] . The distribution and destiny of this interesting cell population have been characterized by histological analysis and it seems that cells enter the lumen of maternal arteries and undergo migration against the Aow of blood, with displacement of the endothelium. At the same time, cells migrate from the interstitium to colonize or invade the maternal arterial media. This process extends as far as the inner myometrial segments of maternal spiral arteries. As a result, the arteries expand and there is increased blood flow to the placenta. Trophoblast migration is complete by approx. 20 weeks, indicating that the phenotype must change with increasing gestation [5] .
Placental villous stem cytotrophoblast is directed into developmental pathways with two distinct end points: villous syncytium, a multinucleate transporting epithelium, or extravillous cytotrophoblast, a migratory cell population with some mesenchymal features [l]. Little is known of the processes that govern the differentiation of stem cytotrophoblast. Furthermore, the mechanisms controlling migration of extravillous trophoblast and its action on maternal arteries are largely unknown.
Explant model of trophoblast migration
Recently an explant model has been useful in defining some of the requirements for trophoblast entry into the extravillous lineage [1, 2, 6, 7] . In this experiment, first-trimester mesenchymal villi (the most peripheral structures of the villous tree) are explanted in serum-free medium on to gel substrates of collagen I or Matrigel. Initial adhesion is followed by a burst of cytotrophoblast proliferation lasting 24-48 h ; this is localized specifically at the site of matrix attachment at the villous tip. As a result, cells are displaced towards the extracellular matrix (ECM) substrate. On collagen I, daughter cells migrate across the gel surface for approx. 5 days, after which activity ceases, leaving a contiguous sheet of cytotrophoblast several cells thick. In cultures on Matrigel, the trophoblast moves into the three-dimensional ECM. One important advantage of this experiment over primary cell culture [8] is that the intricate spatial relationships between cells in the developing cytotrophoblast column are retained, while allowing environmental variables such as ECM and growth factors to be studied.
T h e outgrowing cells display a variety of markers confirming their identity as trophoblast, and indicating a pattern of differentiation that resembles closely that seen in cytotrophoblast columns in vivo. Thus, for example, unlike their precursors in the villous stem cytotrophoblast population, they express HLA framework antigen, and several integrins of thepl family [1, 6] . Notable in the latter group is integrin a5p1, a'high-affinity fibronectin receptor, because the cells also produce large amounts of the oncofetal isoform of fibronectin. This accumulates as thick fibrillar deposits that occupy intercellular spaces within the developing outgrowth. There is a strong resemblance to the distribution of fibronectin observed in cytotrophoblast columns in vivo [9] . T h e explant system provides a model of anchoring site morphogenesis. Because the experiments were all performed with tissue from late in the first trimester (8-1 2 weeks), the observations suggest strongly that new anchoring sites are forming at least until the 12th week of gestation. This might reflect the need of the placenta to continue reinforcing its own anchorage to maternal tissue [2] .
These results also indicate that contact with a permissive ECM is both necessary and sufficient for column development. Explant experiments permit the investigation of the molecular basis of this process. T h e addition of function-blocking antibodies to fibronectin or integrin subunits or5 or pl results in severely disrupted patterns of cell outgrowth, indicating the importance of the interaction of fibronectin with integrin a5pl in 0 2000 Biochemical Society column stability [6] . However, these interventions, although causing loss of the integrity of the cytotrophoblast sheet, do not release the cells into a migratory phenotype, demonstrating that fibronectin-receptor interaction is not responsible for the containment of an inherently migratory cell. It is necessary to seek an alternative explanation for the fact that cells in vitro in fresh serum-free medium do not detach and migrate away from the column periphery as observed in vivo.
Paracrine trigger for cell migration
One source of a signal that might stimulate trophoblast into a migratory phenotype is maternal decidua. However, when mesenchymal villous tissue is co-cultured in direct contact with decidual fragments, extensive trophoblast infiltration of the decidua is not observed [10, 11] . Instead, the pattern of behaviour resembles closely what is seen when placental tissue is explanted on a permissive ECM, with cytotrophoblast columns developing at the sites of contact, and even a spread of cells across the surface of the decidual tissue but only rather limited cell infiltration. In contrast, the cell population of some areas of placental bed decidua can contain as many as 30 yo trophoblast. Thus decidua (presumably via its ECM) has the capacity to trigger column formation but apparently not cell migration.
Another possible source of signals to trophoblast is the adjacent extra-embryonic mesenchyme. Light and electron microscopic studies have shown that, at the base of the columns, mesenchymal cells extend thin processes towards the villous basement membrane, sometimes making direct contact with the stromal aspect of the lamina densa [12] . These cells therefore approach to within a short range of the column.
Several methods have been developed for the isolation of pure populations of mesenchymal cells from first-trimester (and term) placental tissue [13]. When serum-free conditioned medium from these fibroblast cultures is added to first-trimester villous explants on collagen, cytotrophoblast cells detach from the distal column and migrate in streams across the ECM [12] . These results suggest the possibility of a paracrine interaction between villous mesenchyme and cytotrophoblast in anchoring sites to stimulate trophoblast infiltration of the maternal ECM. In principle, such a mechanism is self-limiting because the signal diminishes with increasing distance from the placenta. This novel hypothesis will require substantial further testing because it is currently unclear whether the effect of fibroblast signalling is chemokinetic (i.e. a non-directional increase in cellular motility) or negatively chemotactic (cells migrate down a concentration gradient of diffusible factor).
Insulin-like growth factors (IGFs) as paracrine mediators
Both IGF-I and IGF-I1 mRNA are present in placenta from as early as 6 weeks [14] . Furthermore, IGF-I and IGF-I1 have been detected at physiologically relevant concentrations in the culture medium from various fibroblast strains (C.-.P. Chen, T . Haigh and M. Westwood, unpublished work) . Exogenous IGFs have been tested for the ability to trigger migration in cells outgrowing in explant cultures on collagen. Either of IGF-I or IGF-I1 at 10 ng/ml has the ability to stimulate trophoblast migration in a streaming pattern (H. Lacey, T. Haigh, M. Westwood and J. D. Aplin, unpublished work) . T h e removal of I G F from the fibroblast medium decreases streaming activity, as does the presence of a function-blocking antibody against the I G F receptor type I. In contrast, transforming growth factor 81 (10 ng/ml) decreases the extent of outgrowth and produces no streaming. Transforming growth factor 81 is produced by decidua and has been suggested to act as a negative regulator of trophoblast migration [15-171. T h e IGFs might act to stimulate trophoblast migration either in a paracrine fashion or, for IGF-11, which is produced in cytotrophoblast columns in vivo, via an autocrine mechanism [18] . This action is likely to be modulated by the IGF-binding phosphoprotein IGFBP-1 [19-261, which is an abundant product of decidual tissue [27, 28] .
IGFs in pregnancy
Newborn mice carrying null mutations in the genes encoding IGF-I or IGF-I1 are 40 O h smaller than their normal littermates . IGF-IIdeficient mice also have decreased placental growth but survive normally, whereas mice lacking IGF-I suffer increased neonatal death. Pup size is even smaller if both IGFs (30 yo of normal) or the type 1 I G F receptor (45% of normal) are ablated; these mice die soon after birth. Mice carrying null mutations for both the receptor and IGF-I are identical with those lacking receptor only, whereas mice deficient in IGF-I1 as well as the type 1 I G F receptor resemble those lacking both IGF-I and IGF-11. This suggests that another receptor might be responding to  there is evidence that the insulin receptor, or insulin-IGF receptor 1 hybrids, might be responsible [32] . In humans, the I G F axis is disrupted in disorders of fetal growth: IGF-I levels are decreased in cord sera from intra-uterine growth-restricted (' IUGR ') or small-for-gestational-age (' SGA ') fetuses and are increased in large-for-gestational-age (' LGA') newborns [20] . IGFs can stimulate the proliferation of some trophoblast cell lines in vitro (M. Westwood, unpublished work). It is not yet clear how the placenta might be involved in growth restriction but there is evidence that trophoblast migration into maternal spiral arteries is compromised in IUGR [33] . Thus the control of trophoblast invasion provides an interesting avenue of investigation of placental pathology.
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